NDC 70710-1726
Nelarabine
Nelarabine
Nelarabine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals Usa Inc.. The primary component is Nelarabine.
| Product ID | 70710-1726_aab24c25-6334-49fb-8f02-ad6aba87bafa |
| NDC | 70710-1726 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nelarabine |
| Generic Name | Nelarabine |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-11-17 |
| Marketing Category | ANDA / |
| Application Number | ANDA215037 |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Substance Name | NELARABINE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |